What Are the Key Growth Opportunities in AI-Based Drug Repurposing That You Can Capitalize on?
AI-based drug repurposing is emerging as a new and faster approach to bringing drugs to patients.
Overview
This analysis examines the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI-based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across different disease indications, such as rare diseases, oncology, metabolic diseases, autoimmune diseases, and neurodegenerative diseases.
What are the key growth drivers and restraints in the development of AI-based drug repurposing?
What are the emerging applications of AI in drug repurposing across various therapeutic areas, and which best practices can drive growth?
Who are the key innovators, and what are their approaches to AI-based drug repurposing?
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
